Trial Profile
Clinical Trials Insight: 700034783
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 Jun 2008
Price :
$35
*
At a glance
- Drugs Sulcardine (Primary)
- Indications Arrhythmias
- Focus Adverse reactions
- Sponsors HUYA Bioscience International
- 24 Jun 2008 New trial record.
- 17 Jun 2008 An IND submission for sulcardine is expected to be filed in the first quarter of 2009, according to a media release from HUYA.